These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1776752)

  • 21. Complex visual disturbances in Alzheimer's disease.
    Mendez MF; Mendez MA; Martin R; Smyth KA; Whitehouse PJ
    Neurology; 1990 Mar; 40(3 Pt 1):439-43. PubMed ID: 2314585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neural bases of visual deficits during aging.
    Spear PD
    Vision Res; 1993 Dec; 33(18):2589-609. PubMed ID: 8296455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinal and cortical evoked responses to chromatic contrast stimuli. Specific losses in both eyes of patients with multiple sclerosis and unilateral optic neuritis.
    Porciatti V; Sartucci F
    Brain; 1996 Jun; 119 ( Pt 3)():723-40. PubMed ID: 8673486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of Alzheimer's disease, normal aging and scopolamine on human transient visual evoked potentials.
    Smith AT; Early F; Jones GH
    Psychopharmacology (Berl); 1990; 102(4):535-43. PubMed ID: 2096411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Visual perceptual disorders in Alzheimer's disease].
    Lenoir H; Siéroff É
    Geriatr Psychol Neuropsychiatr Vieil; 2019 Sep; 17(3):307-316. PubMed ID: 31449049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visual-spatial deficits expalin visual symptoms in Alzheimer's disease.
    Butter CM; Trobe JD; Foster NL; Berent S
    Am J Ophthalmol; 1996 Jul; 122(1):97-105. PubMed ID: 8659604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electroretinography and Visual Evoked Potentials in Childhood Brain Tumor Survivors.
    Pietilä S; Lenko HL; Oja S; Koivisto AM; Pietilä T; Mäkipernaa A
    J Child Neurol; 2016 Jul; 31(8):998-1004. PubMed ID: 26945030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Specificity of visual evoked potential alterations in Alzheimer's disease].
    Gilles C; de Buyl O; Genevrois C; Salama M; Mendlewicz J
    Neurophysiol Clin; 1991 Dec; 21(5-6):425-37. PubMed ID: 1808501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of visual impairment in patients with Alzheimer's disease.
    Sadun AA; Borchert M; DeVita E; Hinton DR; Bassi CJ
    Am J Ophthalmol; 1987 Aug; 104(2):113-20. PubMed ID: 3618708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ANNUAL REVIEW: REFRACTION AND VISUAL PHYSIOLOGY.
    BAIR HL; MARTENS TG
    Arch Ophthalmol; 1964 Jun; 71():889-915. PubMed ID: 14133881
    [No Abstract]   [Full Text] [Related]  

  • 31. Alzheimer-like visual deficits in Down syndrome.
    Rocco FJ; Cronin-Golomb A; Lai F
    Alzheimer Dis Assoc Disord; 1997 Jun; 11(2):88-98. PubMed ID: 9194955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sweep visual evoked potential evaluation of contrast sensitivity in Alzheimer's dementia.
    Crow RW; Levin LB; LaBree L; Rubin R; Feldon SE
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):875-8. PubMed ID: 12556424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vision in Alzheimer's disease: a focus on the anterior afferent pathway.
    Pelak VS; Hills W
    Neurodegener Dis Manag; 2018 Feb; 8(1):49-67. PubMed ID: 29359625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pattern electroretinography and pattern visual evoked potentials in maculopathy: a comparison with sensory tests].
    Niermann F; Lorenz R; Heider W
    Fortschr Ophthalmol; 1989; 86(1):54-8. PubMed ID: 2722101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visually evoked potentials and electroretinography in neurologic evaluation.
    Weinstein GW; Odom JV; Cavender S
    Neurol Clin; 1991 Feb; 9(1):225-42. PubMed ID: 1849226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model.
    Criscuolo C; Cerri E; Fabiani C; Capsoni S; Cattaneo A; Domenici L
    Neurobiol Aging; 2018 Jul; 67():181-188. PubMed ID: 29735432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ophthalmologic manifestations of Alzheimer's disease.
    Katz B; Rimmer S
    Surv Ophthalmol; 1989; 34(1):31-43. PubMed ID: 2678551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute ocular methanol toxicity: clinical and electrophysiological features.
    McKellar MJ; Hidajat RR; Elder MJ
    Aust N Z J Ophthalmol; 1997 Aug; 25(3):225-30. PubMed ID: 9296298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Balint's syndrome in Alzheimer's disease: visuospatial functions.
    Mendez MF; Turner J; Gilmore GC; Remler B; Tomsak RL
    Int J Neurosci; 1990 Oct; 54(3-4):339-46. PubMed ID: 2265983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short review of psycho-physiological studies into visual perception in normal and impaired vision.
    Novikova LA
    Int J Rehabil Res; 1984; 7(2):200-3. PubMed ID: 6490278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.